Tris trial is registered with FDA with number: NCT02415439. The sponsor of the trial is ReveraGen BioPharma, Inc. and it is looking for 86 volunteers for the current phase.
Official trial title: A Phase 1 Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VBP15 in Healthy Adult Subjects
Thank you for applying!
We'll contact you soon with more information.
FindMeCure is constantly improving its search. Take part in it and help millions by filling our patients' survey!